JPS63218670A - 2-(2',4'-dihydroxyphenyl)-4-methoxy-5-(3-methylbutyl)-6-hydroxy-coumarone and quality preservative - Google Patents
2-(2',4'-dihydroxyphenyl)-4-methoxy-5-(3-methylbutyl)-6-hydroxy-coumarone and quality preservativeInfo
- Publication number
- JPS63218670A JPS63218670A JP62052248A JP5224887A JPS63218670A JP S63218670 A JPS63218670 A JP S63218670A JP 62052248 A JP62052248 A JP 62052248A JP 5224887 A JP5224887 A JP 5224887A JP S63218670 A JPS63218670 A JP S63218670A
- Authority
- JP
- Japan
- Prior art keywords
- organic solvent
- compound
- dihydroxyphenyl
- methylbutyl
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- FTRRFXDFMYVGTD-UHFFFAOYSA-N 4-[6-hydroxy-4-methoxy-5-(3-methylbutyl)-1-benzofuran-2-yl]benzene-1,3-diol Chemical compound C=1C=2C(OC)=C(CCC(C)C)C(O)=CC=2OC=1C1=CC=C(O)C=C1O FTRRFXDFMYVGTD-UHFFFAOYSA-N 0.000 title claims description 3
- 239000003755 preservative agent Substances 0.000 title abstract 2
- 230000002335 preservative effect Effects 0.000 title abstract 2
- -1 methoxy-5-(3-methylbutyl)-6-hydroxy-coumarone Chemical compound 0.000 claims description 8
- 238000004321 preservation Methods 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 abstract description 19
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 16
- 239000003960 organic solvent Substances 0.000 abstract description 12
- 239000000284 extract Substances 0.000 abstract description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 abstract description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract description 5
- 235000013305 food Nutrition 0.000 abstract description 5
- 239000002904 solvent Substances 0.000 abstract description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract description 4
- 239000000741 silica gel Substances 0.000 abstract description 4
- 229910002027 silica gel Inorganic materials 0.000 abstract description 4
- 239000004378 Glycyrrhizin Substances 0.000 abstract description 3
- 238000004587 chromatography analysis Methods 0.000 abstract description 3
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- 238000000605 extraction Methods 0.000 abstract description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 abstract description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 abstract description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 abstract description 3
- 235000019410 glycyrrhizin Nutrition 0.000 abstract description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract description 3
- 238000010992 reflux Methods 0.000 abstract description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 abstract description 2
- 230000009965 odorless effect Effects 0.000 abstract description 2
- 239000003208 petroleum Substances 0.000 abstract description 2
- 230000009967 tasteless effect Effects 0.000 abstract description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 2
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 2
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 2
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 2
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 230000003026 anti-oxygenic effect Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 241000202807 Glycyrrhiza Species 0.000 description 14
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 14
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 14
- 239000003963 antioxidant agent Substances 0.000 description 14
- 235000006708 antioxidants Nutrition 0.000 description 14
- 229940010454 licorice Drugs 0.000 description 14
- 241000894006 Bacteria Species 0.000 description 11
- 230000003078 antioxidant effect Effects 0.000 description 10
- 230000000844 anti-bacterial effect Effects 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 239000000126 substance Substances 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 235000010384 tocopherol Nutrition 0.000 description 3
- 229960001295 tocopherol Drugs 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- 239000011732 tocopherol Substances 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- YKYONYBAUNKHLG-UHFFFAOYSA-N propyl acetate Chemical compound CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- NZYSZZDSYIBYLC-UHFFFAOYSA-N glycycoumarin Chemical compound C=1C=2C(OC)=C(CC=C(C)C)C(O)=CC=2OC(=O)C=1C1=CC=C(O)C=C1O NZYSZZDSYIBYLC-UHFFFAOYSA-N 0.000 description 1
- NPQWZAAWZLVQIZ-UHFFFAOYSA-N glycycoumarin Natural products COc1cc2OC(=O)C(=Cc2c(O)c1CC=C(C)C)c3ccc(O)cc3O NPQWZAAWZLVQIZ-UHFFFAOYSA-N 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- GJRQTCIYDGXPES-UHFFFAOYSA-N iso-butyl acetate Natural products CC(C)COC(C)=O GJRQTCIYDGXPES-UHFFFAOYSA-N 0.000 description 1
- FGKJLKRYENPLQH-UHFFFAOYSA-M isocaproate Chemical compound CC(C)CCC([O-])=O FGKJLKRYENPLQH-UHFFFAOYSA-M 0.000 description 1
- OQAGVSWESNCJJT-UHFFFAOYSA-N isovaleric acid methyl ester Natural products COC(=O)CC(C)C OQAGVSWESNCJJT-UHFFFAOYSA-N 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000009304 pastoral farming Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000001965 potato dextrose agar Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 229960002385 streptomycin sulfate Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Abstract
Description
【発明の詳細な説明】
産業上の利用分野
本発明は、下記の構造式(I)を有する新規なりマロン
誘導体およびそれを有効成分とする品質保持剤に関する
ものである。DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention relates to a novel malone derivative having the following structural formula (I) and a quality preservation agent containing the same as an active ingredient.
で表される2−(2′,4′・ジヒドロキシフェニル)
−4−メトキシ・5−(3−メチルブチル)−6−ヒド
ロキシ−クマロンおよびこの化合物からなる品質保持剤
に関するものである。2-(2',4'-dihydroxyphenyl) represented by
This invention relates to -4-methoxy.5-(3-methylbutyl)-6-hydroxy-coumarone and a quality preservation agent comprising this compound.
従来の技術
食品、化粧品、医薬品、畜産業、水産業等の分野で製品
の品質が低下する原因には、大きく別けて酸化と腐敗の
2つがある。前者は主として空気中の酸素により化学反
応として起こり、後者は微生物の生育により生物的反応
として起こる。しかし、これら2つは明確に別れている
わけではなく、微生物の生育による酵素反応で酸化が進
行する場合もある。Conventional Technology There are two main causes of deterioration in product quality in the fields of food, cosmetics, pharmaceuticals, livestock farming, fisheries, etc.: oxidation and putrefaction. The former mainly occurs as a chemical reaction due to oxygen in the air, and the latter occurs as a biological reaction due to the growth of microorganisms. However, these two are not clearly separated, and oxidation may proceed due to enzymatic reactions caused by the growth of microorganisms.
一般に、酸化の防止には抗酸化剤が、腐敗の防止には抗
菌剤がそれぞれ使われているが、抗酸化剤で腐敗を、あ
るいは抗菌剤で酸化を防止することはむずかしい。それ
ゆえ製品の品質保持には個々の防止剤を使用せざるをえ
ず、添加物の量がふえるという問題がある。Generally, antioxidants are used to prevent oxidation, and antibacterial agents are used to prevent spoilage, but it is difficult to prevent spoilage with antioxidants or oxidation with antibacterial agents. Therefore, in order to maintain the quality of the product, it is necessary to use individual inhibitors, which poses the problem of increasing the amount of additives.
甘草の有機溶媒抽出物に抗酸化力が有ることは公知であ
り(日本食品工業学会誌;tjg25巻、第25号、1
978)、さらには抗菌力が有ることも公知(特開昭5
9−46210)である。したがって、甘草の有機溶媒
抽出物を有効に利用すれば、酸化防止および腐敗防止の
両方を達成できることになる。甘草の有機溶媒抽出物中
の抗酸化成分や抗菌成分に関する研究もいくつか行なわ
れており、日本食品工業学会誌;第29巻、第7号19
82には抗酸化成分として分子量10,000以上の褐
色メラノイジンよう物質が公表されており、特開昭60
−190784では抗酸化成分と抗菌成分は別個のもの
であり塩基性イオン交換樹脂等で分離できると述べてい
る。It is known that the organic solvent extract of licorice has antioxidant power (Journal of Japan Food Industry Association; TJG Vol. 25, No. 25, 1).
978), and is also known to have antibacterial properties (Japanese Patent Laid-Open No. 5
9-46210). Therefore, if the organic solvent extract of licorice is effectively used, it is possible to achieve both antioxidant and spoilage prevention. Several studies have been conducted on the antioxidant and antibacterial components of organic solvent extracts of licorice, and the journal of Japan Food Industry Association; Vol. 29, No. 7, 19
82, a brown melanoidin-like substance with a molecular weight of 10,000 or more was disclosed as an antioxidant component, and
-190784 states that the antioxidant component and the antibacterial component are separate and can be separated using a basic ion exchange resin or the like.
さらには生薬学雑誌;40(4)、406.1986に
は虫歯原因菌に対する抗菌成分としてグリシロール、イ
ングリシロール、グリシン、グリシクマリンの4成分が
公表されている。Furthermore, the Journal of Pharmacological Sciences; 40 (4), 406.1986 discloses four ingredients, glycilol, inglycilol, glycine, and glycicumarin, as antibacterial ingredients against caries-causing bacteria.
このように、甘草の有機溶媒抽出物は抗酸化剤、抗菌剤
として有用であるが、赤褐色の色と特有のにおいが有る
ためその使用が制限されているのが現状であった。As described above, organic solvent extracts of licorice are useful as antioxidants and antibacterial agents, but their use is currently limited due to their reddish-brown color and unique odor.
問題点を解決するための手段
本発明は、甘草より得られた新規化合物2−(2′,4
′−ジヒドロキシフェニル)−4−メトキシ・5−(3
−メチルブチル)−6−ヒドロキシ・クマロンおよびこ
の化合物からなる品質保持剤により上述の目的を達成し
たものである。Means for Solving the Problems The present invention provides a novel compound 2-(2',4) obtained from licorice.
'-dihydroxyphenyl)-4-methoxy 5-(3
-Methylbutyl)-6-hydroxy coumaron and a quality preservation agent comprising this compound have achieved the above-mentioned object.
すなわち、本発明者は甘草から得られる抗酸化性物質お
よび抗菌性物質について研究して来たところ、有機溶媒
を用いて抽出した成分をシリカゲル、セファデックス等
のクロマトグラフィーにより精製することで、前記(I
)式で示される新規化合物を単離し、かつこのものが強
い抗酸化性と抗菌性を有し品質保持剤として有効に使用
し得ることを見出し本発明を完成した。That is, the present inventor has been researching antioxidant substances and antibacterial substances obtained from licorice, and found that by purifying the components extracted using an organic solvent by chromatography using silica gel, Sephadex, etc. (I
The present invention was completed by isolating a novel compound represented by the formula () and discovering that it has strong antioxidant and antibacterial properties and can be effectively used as a quality preservation agent.
本発明に係る新規化合物2−(2′,4′−ジヒドロキ
シフェニル)−4−メトキシ−5−(3−メチルブチル
)−6−ヒドロキシ−クマロンは、前記(I)式で示さ
れる化学構造を有し、無色針状結晶で、後述する特性値
を有する。The novel compound 2-(2',4'-dihydroxyphenyl)-4-methoxy-5-(3-methylbutyl)-6-hydroxy-coumaron according to the present invention has a chemical structure represented by the above formula (I). It is a colorless acicular crystal and has the characteristic values described below.
本発明の新規化合物は、甘草またはその水(もしくは水
性媒体)抽出液(たとえば甘草からグリチルリチンを抽
出した後の残渣)を下記の溶媒で抽出処理して得られる
物である:
メタノール、エタノール等の低級脂肪族アルコール;ア
セトン等の低級脂肪族ケトン;ジオキサン、エチルエー
テル等の低級脂肪族エーテル;石油エーテル、n−ヘキ
サン、シクロヘキサン、トルエン、ベンゼン等の揮発性
炭化水素;メチレン、クロロホルムなど炭素原子数が1
〜4のハロゲン化炭化水素;酢酸エチル、酢酸n−プロ
ピル、酢酸n−ブチル、酢酸イソブチルなど炭素原子数
3〜7のエステル:およびこれらの溶媒の2種以上の混
合物。The novel compound of the present invention is obtained by extracting licorice or its aqueous (or aqueous medium) extract (for example, the residue after extracting glycyrrhizin from licorice) with the following solvents: methanol, ethanol, etc. Lower aliphatic alcohols; Lower aliphatic ketones such as acetone; Lower aliphatic ethers such as dioxane and ethyl ether; Volatile hydrocarbons such as petroleum ether, n-hexane, cyclohexane, toluene, and benzene; Number of carbon atoms such as methylene and chloroform is 1
~4 halogenated hydrocarbons; esters having 3 to 7 carbon atoms such as ethyl acetate, n-propyl acetate, n-butyl acetate, and isobutyl acetate; and mixtures of two or more of these solvents.
上記有機溶媒による抽出は、被処理原料を約3〜5倍量
の有機溶媒に浸漬して還流下に加熱するほか、約5〜I
O倍量の有機溶媒に常温で浸漬することにより行う。Extraction with the above organic solvent involves immersing the raw material to be treated in about 3 to 5 times the volume of the organic solvent and heating it under reflux.
This is carried out by immersion in O times the amount of organic solvent at room temperature.
有機溶媒抽出物から本発明の新規化合物の精製は、有機
溶媒抽出液から溶媒を留去した後メタノール、エタノー
ル等の低級脂肪族アルコールに抽出物を溶解し、その後
シリカゲルおよびセファデックス等のクロマトグラフィ
ーにより行う。Purification of the novel compound of the present invention from an organic solvent extract involves distilling off the solvent from the organic solvent extract, dissolving the extract in a lower aliphatic alcohol such as methanol or ethanol, and then chromatography using silica gel or Sephadex. This is done by
本発明に使用する甘草は、東北産、西北産、あるいはモ
ンゴル産甘草が好ましく、新彊産、ソ連産甘草は好まし
くない。The licorice used in the present invention is preferably licorice from Tohoku, northwest, or Mongolia, and licorice from Xinjiang or the Soviet Union is not preferred.
本発明の化合物は、無味無臭でありあらゆる食品、化粧
品、医薬品、畜産業、水産業等の分野で製品の品質保持
に有効である。The compound of the present invention is tasteless and odorless, and is effective in maintaining the quality of products in all fields of food, cosmetics, pharmaceuticals, livestock industry, fisheries industry, etc.
本発明の化合物の好適添加量は、所望の品質保持期間に
応じて任意に選ぶことができるが、多くの場合製品の0
.0003〜0.035重量%、望ましくは0.002
5〜0.02重量%とすることにより好結果を得ること
ができる。The suitable amount of the compound of the present invention to be added can be arbitrarily selected depending on the desired quality retention period, but in many cases
.. 0003-0.035% by weight, preferably 0.002
Good results can be obtained by setting the content to 5 to 0.02% by weight.
本発明の化合物は単独で用いるほかに、既存の抗酸化性
物質たとえば、トコフェロール、BHA、BHT、 没
食子酸およびその誘導体、アスコルビン酸およびその塩
、クエン酸およびその塩、またはEDTABよびその塩
や、既存の抗菌性物質たとえば、ソルビン酸、グリシン
、縮合リン酸塩、エタノール、プロピレングリコール、
リゾチーム、グリセリン脂肪酸エステル、ショ糖脂肪酸
エステル、酢酸ソーダ、有機酸などと組み合わせて使用
できる。本発明の化合物の品質保持作用は、これらの化
合物によって何らの悪影響も受けず、むしろ相乗作用に
より一層品質保持作用を高めることがある。In addition to being used alone, the compound of the present invention can also be used with existing antioxidant substances such as tocopherol, BHA, BHT, gallic acid and its derivatives, ascorbic acid and its salts, citric acid and its salts, or EDTAB and its salts, Existing antibacterial substances such as sorbic acid, glycine, condensed phosphates, ethanol, propylene glycol,
Can be used in combination with lysozyme, glycerin fatty acid ester, sucrose fatty acid ester, sodium acetate, organic acids, etc. The quality-preserving effect of the compounds of the present invention is not adversely affected by these compounds, but rather may be further enhanced by a synergistic effect.
実施例 以下、実施例を示して本発明を説明する。Example The present invention will be explained below with reference to Examples.
実施例 l
下記の方法にて 2−(2′,4′−ジヒドロキシフェ
ニル)=4−メトキシ−5−(3−メチルブチル)−6
−ヒドロキシークマロンを製造した。Example 1 2-(2',4'-dihydroxyphenyl)=4-methoxy-5-(3-methylbutyl)-6 by the following method
-Hydroxy-coumaron was produced.
西北産甘草3.5kgを17.511のクロロホルムと
ともに2時間還流下に加熱してクロロホルム可溶成分を
抽出した。この抽出液の溶媒を留去し、さらに50%エ
タノールに溶解させ、50%エタノール可溶部約50g
を得た。この50%エタノール可溶物を順相シリカゲル
(クロロホルム:メタノール−40: 1)で分画し、
つぎにセファデックスLH−20で処理し、2−(2′
,4′−ジヒドロキシフェニル)・4−メトキシ・5−
(3−メチルブチル)−6−ヒドロキシ−クマロン 8
2Bを得た。得られた化合物は、次の性質および機器分
析値を示すものである。3.5 kg of licorice from northwest Japan was heated under reflux for 2 hours with 17.511 chloroform to extract chloroform-soluble components. The solvent of this extract was distilled off, and it was further dissolved in 50% ethanol, and the 50% ethanol soluble portion was approximately 50 g.
I got it. This 50% ethanol soluble material was fractionated with normal phase silica gel (chloroform:methanol-40:1),
Next, it was treated with Sephadex LH-20 and 2-(2'
,4'-dihydroxyphenyl)・4-methoxy・5-
(3-Methylbutyl)-6-hydroxy-coumarone 8
I got 2B. The obtained compound exhibits the following properties and instrumental analysis values.
分子式: Ct。HzoOs
分子量:340.38
性状:無色針状結晶
元素分析:計算値(%) C;70.5B、H;5.
92実測値(%) C;70.04 H;5.90
融点:183〜186℃
I Ry二:二 am−’ : 3350,16
H,1600,1510,1320,180,HHUV
λ:::’nm(E lj : 3!1(1157,
5)、336(992,5)MS tact : 34
0,2g5j14,270,269’H−NMRδ(p
pm)(CD30D):xro+utic ABX系、
7.56(d、J=L(Hx)645(dd、J=1
411g、2,2■!; d、J−2Hx)sro+u
tic singlet、 7.151ar*nic
5iBlet、 6.70isopentenyl (
romp、 1.H,1,73QxCH3)344(d
J藁9.2Ht、 CHt)5.17(J −9,2H
x、 =CL)melbox71 (ro++p、
395”C−NMRδ(ppmXd・−DMSO):1
7.56(Q)、 2130(t)、 !5.49
(Q)、 5L70(Q)、 92.17(d)+
0044(d)、 +010(d)、 +og、u(d
)、 +0111(S)、 +1155(S)114.
06(s)、 H3,91(d)、 H6,54(d)
、 09.30(s)、 150.06(s)150.
35(s)、 153.1to(s)、 153.11
(s)、 155.23(s)、 151.05(s)
実施例 2
下記の処方で油脂A−Fを製造した。Molecular formula: Ct. HzoOs Molecular weight: 340.38 Properties: Colorless acicular crystals Elemental analysis: Calculated value (%) C; 70.5B, H; 5.
92 Actual value (%) C; 70.04 H; 5.90
Melting point: 183-186°C I Ry2:2 am-': 3350,16
H, 1600, 1510, 1320, 180, HHUV
λ:::'nm(E lj : 3!1(1157,
5), 336 (992,5) MS tact: 34
0,2g5j14,270,269'H-NMRδ(p
pm) (CD30D): xro+utic ABX series,
7.56(d, J=L(Hx)645(dd, J=1
411g, 2,2■! ; d, J-2Hx) sro+u
tic singlet, 7.151ar*nic
5iBlet, 6.70isopentenyl (
romp, 1. H, 1,73QxCH3) 344(d
J straw 9.2Ht, CHt) 5.17 (J -9,2H
x, =CL) melbox71 (ro++p,
395”C-NMRδ (ppmXd・-DMSO): 1
7.56(Q), 2130(t), ! 5.49
(Q), 5L70(Q), 92.17(d)+
0044(d), +010(d), +og, u(d
), +0111(S), +1155(S)114.
06(s), H3,91(d), H6,54(d)
, 09.30 (s), 150.06 (s) 150.
35(s), 153.1to(s), 153.11
(s), 155.23(s), 151.05(s)
Example 2 Fats and oils A-F were manufactured using the following formulations.
BCDEF
本発明化合物 low(
グリシクマリン lO謹2グリチルリ
チン IOB天然トコフェロール
IOB甘草のクロロホルム抽出
物 IOH精製ラード
1001100(IOJ 100(1001100(こ
れらの油脂A−FについてAOM試験を行ない、POv
が20に達するまでの時間T、。を測定した結果は次の
とおりであった。BCDEF Compound of the present invention low (glycycoumarin 1O2 glycyrrhizin IOB natural tocopherol IOB licorice chloroform extract IOH purified lard
1001100 (IOJ 100 (1001100) (AOM test was conducted on these oils and fats A-F, POv
The time T required for T to reach 20. The results of the measurements were as follows.
油脂 T2゜(時間) A 2.4 8 48、O C3,8 D 2.5 E 12.O F 10.0 実施例 3 下記の処方で油脂A−Dを製造した。Fats and oils T2゜ (hours) A 2.4 8 48, O C3,8 D 2.5 E 12. O F 10.0 Example 3 Fats and oils A-D were manufactured using the following formulations.
BCD
本発明化合物 20B天然トコフエロ
ール 211B甘草のクロロホルム抽出
’k 20 m (ナタネ油
100(100(100t 100(これら
の油脂A−FについてAOM試験を行ない、POvが1
00に達するまでの時間T、。。を測定した結果は次の
とおりであった。BCD Compound of the present invention 20B Natural tocopherol 211B Chloroform extraction of licorice 'k 20 m (rapeseed oil
100 (100 (100t) 100 (AOM test was conducted on these oils and fats A-F, and POv was 1
Time T until reaching 00. . The results of the measurements were as follows.
油脂 T+ao(時間)
A 20.O
B 32.2
CI8.0
D 24.0
実施例 4
本発明化合物、グリシクマリンおよび対照としてストレ
プトマイシンスルフェートの三化合物について下記1〜
7の細菌、酵母およびカビに対する抗菌力を下記の方法
により試験した。Fats and oils T+ao (hours) A 20. OB 32.2 CI8.0 D 24.0 Example 4 The following 1 to 3 compounds of the present invention, glycicumarin, and streptomycin sulfate as a control were tested.
The antibacterial activity of No. 7 against bacteria, yeast, and mold was tested by the following method.
1、5taphylococcus aureus、
2.Bacillus 5ubtilis3、 Es
ch@richia coli、 4. Sac
charomyces cerevisiae5、Ca
ndida utilis、 6.Pic
hia nakawawa*7.Rh1zopus f
ornossnsis被験菌液の調整は次の様に行った
。細菌(1〜3)は、標準寒天斜面培地で30’03日
間培養し、酵母、カビ(4〜7)は、ポテトデキストロ
ース寒天斜面培地で30℃3日間培養した。この培養菌
から使用直前に菌または胞子をかきとり滅菌生理食塩水
5mlにけん濁して被験菌液とした。1, 5taphylococcus aureus,
2. Bacillus 5ubtilis3, Es
ch@richia coli, 4. Sac
charomyces cerevisiae5, Ca
ndida utilis, 6. Pic
hia nakawawa*7. Rh1zopus f
The test bacterial solution of P. ornossnsis was prepared as follows. Bacteria (1-3) were cultured on standard agar slants for 30'03 days, and yeasts and molds (4-7) were cultured on potato dextrose agar slants at 30°C for 3 days. Immediately before use, bacteria or spores were scraped from the cultured bacteria and suspended in 5 ml of sterile physiological saline to prepare a test bacterial solution.
一方、所定濃度の三化合物溶液1mlを滅菌シャーレ(
9c+Blx2cm)にとり、これに予め121’01
5分間滅菌旭理した標準寒天培地19m1を加えて十分
混合し、平板固化する。上記の被験菌液から1白金耳平
板に塗布して30℃で培養する。細菌は1日後、酵母、
カビは3日後の菌の生育を観察した。On the other hand, pour 1 ml of the three-compound solution at a predetermined concentration into a sterile petri dish (
9c+Blx2cm) and add 121'01 to this in advance.
Add 19 ml of standard agar medium that has been sterilized for 5 minutes, mix well, and solidify on a plate. One platinum loop plate is coated with the above test bacterial solution and cultured at 30°C. After one day, the bacteria become yeast,
The growth of fungi was observed after 3 days.
その結果を次に示す。The results are shown below.
被検菌: Stspk71ococcms amrem
s被験菌: Bxcilllns 5ubtilis被
験菌: Escherichia coli被験菌:
Ssccbsromyces cerevisiae被
験薗:C1鳳didi t+Li1is被験菌: Pi
cbia nakawswie被験菌: Rh1zop
us formose++5is(注)表中の記号
一:コロニー認めず
+:コロニー発生
発明の効果
実施例で示したとおり、本発明の化合物は強い抗酸化作
用および抗菌作用を兼ね備えており、すぐれた品質保持
効果がある。こうした品質保持力は従来の単なる抗酸化
剤、抗菌剤では側底達成されない高水準のものである。Test bacteria: Stspk71ococcms amrem
sTest bacteria: Bxcillns 5ubtilisTest bacteria: Escherichia coliTest bacteria:
Ssccbsromyces cerevisiae Test strain: C1 Otori t + Liis Test strain: Pi
cbia nakawswie Test bacterium: Rh1zop
us formose++5is (Note) Symbol 1 in the table: No colonies observed +: Colony occurrence Effect of the invention As shown in the examples, the compound of the present invention has both strong antioxidant and antibacterial effects, and has an excellent quality retention effect. There is. This quality retention ability is at a high level that cannot be achieved with conventional simple antioxidants and antibacterial agents.
したがって、本発明によれば、製品の品質保持のため抗
酸化剤、抗菌剤を別々に加える必要がなく、しかもごく
少量の添加により製品の品質を良好に保つことができる
。Therefore, according to the present invention, it is not necessary to separately add an antioxidant and an antibacterial agent to maintain the quality of the product, and the quality of the product can be maintained in good condition by adding only a small amount.
Claims (2)
−メトキシ−5−(3−メチルブチル)−6−ヒドロキ
シ−クマロン。(1) 2-(2',4'-dihydroxyphenyl)-4
-Methoxy-5-(3-methylbutyl)-6-hydroxy-coumaron.
−メトキシ−5−(3−メチルブチル)−6−ヒドロキ
シ−クマロンを有効成分として含有する品質保持剤。(2) 2-(2',4'-dihydroxyphenyl)-4
-A quality preservation agent containing methoxy-5-(3-methylbutyl)-6-hydroxy-coumarone as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62052248A JP2566771B2 (en) | 1987-03-09 | 1987-03-09 | 2- (2,4-dihydroxyphenyl) -4-methoxy-5- (3-methyl-2-butenyl) -6-hydroxycoumarone and preservative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62052248A JP2566771B2 (en) | 1987-03-09 | 1987-03-09 | 2- (2,4-dihydroxyphenyl) -4-methoxy-5- (3-methyl-2-butenyl) -6-hydroxycoumarone and preservative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63218670A true JPS63218670A (en) | 1988-09-12 |
JP2566771B2 JP2566771B2 (en) | 1996-12-25 |
Family
ID=12909430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62052248A Expired - Lifetime JP2566771B2 (en) | 1987-03-09 | 1987-03-09 | 2- (2,4-dihydroxyphenyl) -4-methoxy-5- (3-methyl-2-butenyl) -6-hydroxycoumarone and preservative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2566771B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001007031A1 (en) * | 1999-07-26 | 2001-02-01 | Shionogi & Co., Ltd. | Benzene derivatives and immunopotentiating compositions or drug-sensitivity restoring agents containing the same |
EP1240831A3 (en) * | 2001-03-15 | 2003-06-04 | Takasago International Corporation | Color fading/discoloration preventive agent |
FR2833165A1 (en) * | 2001-12-10 | 2003-06-13 | Oreal | Cosmetic or pharmaceutical compositions useful for inhibiting protein glycation, comprise hydroxylated benzofuran derivatives |
WO2022030443A1 (en) * | 2020-08-07 | 2022-02-10 | キッコーマン株式会社 | Food/beverage article |
-
1987
- 1987-03-09 JP JP62052248A patent/JP2566771B2/en not_active Expired - Lifetime
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001007031A1 (en) * | 1999-07-26 | 2001-02-01 | Shionogi & Co., Ltd. | Benzene derivatives and immunopotentiating compositions or drug-sensitivity restoring agents containing the same |
EP1240831A3 (en) * | 2001-03-15 | 2003-06-04 | Takasago International Corporation | Color fading/discoloration preventive agent |
FR2833165A1 (en) * | 2001-12-10 | 2003-06-13 | Oreal | Cosmetic or pharmaceutical compositions useful for inhibiting protein glycation, comprise hydroxylated benzofuran derivatives |
WO2022030443A1 (en) * | 2020-08-07 | 2022-02-10 | キッコーマン株式会社 | Food/beverage article |
Also Published As
Publication number | Publication date |
---|---|
JP2566771B2 (en) | 1996-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101140194B1 (en) | Antibacterial agent and external preparation for skin containing the same | |
JP3635081B2 (en) | Whitening agents, antioxidants, collagenase activity inhibitors, hyaluronidase activity inhibitors, anti-aging agents, external preparations for skin, cosmetics and foods | |
JP2005531641A (en) | Process for producing hydroxytyrosol ester, ester obtained by the process and use of the ester | |
EP2379484B1 (en) | Polyunsaturated fatty acid and diol ester as an anti-acne agent | |
JPS63218670A (en) | 2-(2',4'-dihydroxyphenyl)-4-methoxy-5-(3-methylbutyl)-6-hydroxy-coumarone and quality preservative | |
WO2013070030A1 (en) | Composition containing 3-dodecanoyloxy-2-isobutyryloxy-4-methylpentanoic acid as active ingredient | |
JP2848688B2 (en) | Oral composition | |
DE10335634B4 (en) | Use of perilla-, geranium- and citronellic acid as well as selected derivatives for preservation, for the treatment of acne, dandruff or dematomycoses as well as for combating body odor-causing microorganisms | |
JPH09278666A (en) | Antimicrobial agent and its production | |
EP1926726B1 (en) | Non-fluorescent chlorophyll catabolites | |
JP3936968B2 (en) | Antibacterial agents derived from natural products, antibacterial fragrances, and cosmetics containing them | |
JP2010180137A (en) | Antimicrobial agent | |
JPS60166645A (en) | Benzoic acid derivative, manufacture and use drug, fungicideor antiseptic | |
US20130035299A1 (en) | Antimicrobial composition based on botanical extracts from oil palm vegetation liquor | |
JP6931227B2 (en) | Moisturizer | |
EP3389731B1 (en) | Antibacterial composition containing a deoxyhexose alkyl monoacetal or monoether | |
DE10308278B4 (en) | Antimicrobial agents against bacteria, yeasts and molds | |
KR20190083983A (en) | Composition for antioxidant or antimicrobial containing Cosmos bipinnatus flower extract | |
CN112544620B (en) | Anticorrosive composition and preparation method thereof | |
DE3003096A1 (en) | USE OF O-METHOXYZIMTALDEHYDE AS A PROTECTIVE AGENT FOR MATERIALS OR PRODUCTS THAT ARE DENATURED BY THE EFFECT OF MICROORGANISMS | |
JPH02286608A (en) | Sterilizing composition | |
EP0818143B1 (en) | Food grade bactericidal composition and process for its use | |
JP2006052184A (en) | Food for inhibiting oxidation stress | |
CN115089504A (en) | Novel cosmetic compositions, process for their preparation and their use | |
JPH0543445A (en) | Skin medicine for external use |